Lindbrook Capital, LLC Dbv Technologies S.A. Transaction History

Lindbrook Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$1.22 - $1.77 $1,793 - $2,601	-1,470 Closed	0 $0
Q4 2021 Jan 18, 2022	BUY	$1.39 - $5.58 $839 - $3,370	604 Added 69.75%	1,470 $2,000
Q3 2021 Nov 05, 2021	BUY	$4.71 - $5.92 $4,078 - $5,126	866 New	866 $4,000
Q3 2020 Nov 03, 2020	SELL	$1.58 - $4.77 $682 - $2,060	-432 Closed	0 $0
Q1 2020 Apr 22, 2020	SELL	$2.33 - $12.98 $633 - $3,530	-272 Reduced 38.64%	432 $2,000
Q2 2019 Jul 24, 2019	BUY	$7.58 - $10.0 $2,683 - $3,540	354 Added 101.14%	704 $5,000
Q1 2019 Apr 23, 2019	SELL	$5.81 - $9.37 $1,824 - $2,942	-314 Reduced 47.29%	350 $2,000
Q4 2018 Feb 07, 2019	BUY	$5.75 - $21.85 $3,818 - $14,508	664 New	664 $4,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $599M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.